Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01519596 · ClinicalTrials.gov registry record · NA
Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01519596 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 70 participants.
The verdict
NCT01519596, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a randomized clinical trial that studies symptom-adapted physical activity intervention in minimizing physical function decline in older patients with acute myeloid leukemia (AML) undergoing chemotherapy. Physical activity may help decrease functional impairment and improve the quality of life in patients with AML undergoing chemotherapy.
Interventions
- PROCEDURE quality-of-life assessment
- BEHAVIORAL exercise intervention
- OTHER educational intervention
- OTHER counseling intervention
- PROCEDURE standard follow-up care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-10 |
| Est. Completion | 2017-02-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01519596
The ClinicalTrials.gov registry entry for NCT01519596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which quality-of-life assessment is the first listed.
NCT01519596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01519596 about?
NCT01519596 is a clinical study titled "Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy". This is a randomized clinical trial that studies symptom-adapted physical activity intervention in minimizing physical function decline in older patients with acute myeloid leukemia (AML) undergoing chemotherapy. Physical activity may help decrease functional impairment and improve the quality of li...
What is the current status of trial NCT01519596?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2012-10. Estimated completion is 2017-02-05.
What interventions are being tested in trial NCT01519596?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), exercise intervention (BEHAVIORAL), educational intervention (OTHER), counseling intervention (OTHER), standard follow-up care (PROCEDURE).
Who is sponsoring clinical trial NCT01519596?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.